Systemic responses after bronchial aspirin challenge in sensitive patients with asthma  Joanna S. Makowska, MD, PhD, Janina Grzegorczyk, PhD, Barbara Bienkiewicz,

Slides:



Advertisements
Similar presentations
Bronchial challenges in athletes applying to inhale a β2-agonist at the 2004 Summer Olympics Sandra D. Anderson, PhD, DSc, Malcolm Sue-Chu, MB ChB, PhD,
Advertisements

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
D-dimer: A biomarker for antihistamine-resistant chronic urticaria
Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
Alveolar nitric oxide and asthma control in mild untreated asthma
The use of serum-specific IgE measurements for the diagnosis of peanut, tree nut, and seed allergy  Jennifer M. Maloney, MD, Magnus Rudengren, BSc, Staffan.
Allergen immunotherapy: A practice parameter third update
Clarification concerning amoxicillin skin testing
High-titer IgE antibody specific for pollen allergens in northern California is associated with both wheezing and total serum IgE  Elizabeth A. Erwin,
Fatty acids, inflammation, and asthma
Advances in food allergy in 2015
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Major rabbit allergen Ory c 3: What could be its possible role as a sensitizing agent in real life?  Gennaro Liccardi, MD, Antonello Salzillo, MD, Maria.
David A. Khan, MD  Journal of Allergy and Clinical Immunology 
Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD 
Is 9 more than 2 also in allergic airway inflammation?
Desensitization to Chemotherapeutic Agents
Jack Pepys' contributions to the medical literature
Fatty acids, inflammation, and asthma
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Allergy testing in predicting outcome of open food challenge to peanut
Peter M. Wolfgram, MD, David B. Allen, MD 
Etiology of asthma exacerbations
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug–related urticaria and angioedema  Marek L.
Debra J. Palmer, PhD, Thomas R. Sullivan, BMa&CompSc(Hons), Michael S
Phillip Lieberman, MD, Michael Tankersley, MD 
A survivor: The eosinophil as a regulator in asthma
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
Early decreases in blood eosinophil levels with reslizumab
The Editors' Choice Journal of Allergy and Clinical Immunology
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
Anaphylactic Reaction to White-Faced Hornet Sting and Elevated Baseline (Asymptomatic) Serum Tryptase  Phillip Lieberman, MD, Lawrence B. Schwartz, MD,
News Beyond Our Pages Journal of Allergy and Clinical Immunology
A cluster-randomized trial shows telephone peer coaching for parents reduces children's asthma morbidity  Jane M. Garbutt, MB, ChB, Yan Yan, MD, PhD,
Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
Claus Bachert, MD, PhD, Cezmi A. Akdis, MD 
Lisa G. Wood, PhD, Manohar L. Garg, PhD, Peter G. Gibson, MBBS 
Airway inflammation in occupational asthma caused by styrene
What is an “eosinophilic phenotype” of asthma?
Immune responses to mosquito saliva in 14 individuals with acute systemic allergic reactions to mosquito bites  Zhikang Peng, MD, Andrew N. Beckett, BSc,
H. William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Autophagy: Nobel Prize 2016 and allergy and asthma research
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Advances in the approach to the patient with food allergy
Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells  Sun Ying, MD, PhD,
Sara Paveglio, PhD, MS, Erin Bennett, MS, Kelly L. Hawley, PhD, Adam P
Corinne A. Keet, MD, MS, Wayne G. Shreffler, MD, PhD, Roger D
Protection by budesonide and fluticasone on allergen-induced airway responses after discontinuation of therapy  Padmaja Subbarao, MD, MSc, Sandra C. Dorman,
Risk of oral food challenges
Benjamin Chaigne, MD, Hervé Watier, MD, PhD 
Xiu-Min Li, MD, LaVerne Brown, PhD 
Measles and immunomodulation
Macrolide antibiotics and asthma treatment
Immune pathomechanism of drug hypersensitivity reactions
Statistical issues in clinical trials that involve the double-blind, placebo-controlled food challenge  Vernon M. Chinchilli, PhD, Laura Fisher, MD, Timothy.
Asthma: The past, future, environment, and costs
Interrupting IL-6–receptor signaling improves atopic dermatitis but associates with bacterial superinfection  Alexander A. Navarini, MD, PhD, Lars E.
Environmental factors and eosinophilic esophagitis
Kinase inhibitors in clinical practice: An expanding world
The GILL study: Glycerin-induced local reactions in immunotherapy
The use of serum-specific IgE measurements for the diagnosis of peanut, tree nut, and seed allergy  Jennifer M. Maloney, MD, Magnus Rudengren, BSc, Staffan.
Advances in pediatric asthma in 2007
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Safety and efficacy of repeated monthly carboplatin desensitization
Natural history of cow’s milk allergy
Primary prevention of asthma and allergy
Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years  Malgorzata Setkowicz, MD, PhD, Lucyna Mastalerz,
Advances in mechanisms of allergic disease in 2016
Presentation transcript:

Systemic responses after bronchial aspirin challenge in sensitive patients with asthma  Joanna S. Makowska, MD, PhD, Janina Grzegorczyk, PhD, Barbara Bienkiewicz, MD, PhD, Maria Wozniak, MD, PhD, Marek L. Kowalski, MD, PhD  Journal of Allergy and Clinical Immunology  Volume 121, Issue 2, Pages 348-354 (February 2008) DOI: 10.1016/j.jaci.2007.09.039 Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Blood for flow cytometry and cytokine analysis was collected at the following time points: P0, before placebo inhalation; P1, 1 hour after completion of placebo administration; P20 = A0, 20 hours after placebo administration (the baseline for aspirin challenge); A1, 1 hour after aspirin-induced reaction (in patients with positive reaction) or 1 hour after completion of aspirin administration (in patients with negative challenge); A20, 20 hours after reaction caused by aspirin (in patients with positive reaction) or 1 hour after completion of aspirin administration (in patients with negative challenge). Journal of Allergy and Clinical Immunology 2008 121, 348-354DOI: (10.1016/j.jaci.2007.09.039) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 The percentage of leukocyte progenitor cells (A) and eosinophil progenitor cells (B) after bronchial challenge with lysine-aspirin in patients with negative and positive reaction (∗P < .05, ∗∗P < .005 compared with A0). Journal of Allergy and Clinical Immunology 2008 121, 348-354DOI: (10.1016/j.jaci.2007.09.039) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 The percentage of leukocyte progenitor cells (A) and eosinophil progenitor cells (B) after bronchial challenge with lysine-aspirin in patients with isolated bronchial reactions, systemic reactions, and negative response (∗P < .05; ∗∗P < .005 compared with A0). Journal of Allergy and Clinical Immunology 2008 121, 348-354DOI: (10.1016/j.jaci.2007.09.039) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 4 Serum concentrations of eotaxin 2 after bronchial challenge with lysine-aspirin in patients with positive and negative response (∗P < .05 compared with A0). Journal of Allergy and Clinical Immunology 2008 121, 348-354DOI: (10.1016/j.jaci.2007.09.039) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions